(BFM Stock Exchange) – This article, with free access, is produced by the research team in BFM Stock Exchange analysis and market strategy. To not miss any opportunity, consult all of the analyzes and discover our portfolios by accessing our privilege space.
The company benefits from a defensive profile in the current market context, with a title that has remained stable and close to its highest annuals despite tensions related to customs duties. It also displays solid perspectives, tabling on two -digit growth in its net profit in the years to come. The title is currently negotiated under the average of its historic valuation.

Key graphics elements

Technically, the title evolves in a ranging trading, typically interpreted as a figure of continuation. In the context of a preexisting upward trend, the probabilities are leaning in favor of an exit from above, with a theoretical objective located around 130 euros in the event of crossing.

FORECAST

In view of the key graphic factors that we have mentioned, our opinion is bullish on the biomoting action in the short term.

Active investors will take a position on the purchase on the biomoting title during € 116,300 with a target at € 130,000 in line. They will protect their capital by placing a stop at € 108,500.

The News Bulletin 247 Council

Biomitious
Positive 116,300 €
Objective :
130,000 €
Potential :
+11.78 %
Stop:
€ 108,500
Resistance (s):
120,000 / 130,000
Support (s):
111.100 / 103,000 / 96,500

Daily data graphics